s
Norgine receives positive CHMP opinion recommending approval of NPJ5008 (dantrolene sodium hemiheptahydrate) for the treatment of malignant hyperthermia
26-03-2024, 16:57
AMSTERDAM, March 26, 2024 /PRNewswire/ — Norgine B.V. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of NPJ5008 (dantrolene sodium hemiheptahydrate) for the treatment of malignant hyperthermia. The European Commission (EC) will now review the CHMP’s recommendation. […] L'articolo Norgine receives positive CHMP opinion recommending approval of NPJ5008 (dantrolene sodium hemiheptahydrate) for the treatment of malignant hyperthermia proviene da La Ragione.
CONTINUA A LEGGERE
7
0
0
La Ragione
22:12
Le Pen: “La marea cresce, la nostra vittoria è solo rimandata”
La Ragione
19:43
Keys si fa male e si ritira, Paolini ai quarti di Wimbledon
La Ragione
19:34